skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have been holding BIIB for a couple of years on hopes (I know, that is not an investment strategy) that their alzheimer drug would be approved. It has come close a few times and the stock has reacted very favourably only to fall short of approval and fall back in price. Do you believe that the recent setback will make BIIB dead money for the foreseeable future and its best to move on or is it too cheap and compelling a story to sell now? If BIIB was part of your US Growth portfolio would you keep it or sell in favour of a better growth stock. If your decision would be to sell, what would be the top 2 names for replacement with no regard to sector.

Thanks
Scott
Read Answer Asked by Scott on November 19, 2020
Q: Hi 5i,
In their latest quarter results, they did beat the estimates. Remdesivir is still a one of the most used drug treatment. My opinion is that it will still be continued to be used for treatment till a better one is found.
Not sure why market is not so excited about the results and future prospects. Can you clarify.
Thanks for your sound advise.
Read Answer Asked by Vinod on November 17, 2020
Q: I am interested why you would recommend Cloud MD (Doc). Is it because it's share price has increased by the graces of companies like Teladoc and Well, or do you think their promotional approach will result in a successful business model? I am old enough to remember Patient Home Monitoring (phm). Similarities here?
Read Answer Asked by Rashida on November 16, 2020
Q: I do not have any Health Care and am looking for an ETF. What is your opinion of ZUH.CA. How would you rate the BMO ETF's? What other two Health Care ETF's should be considered.
Thank you.
Read Answer Asked by Nadine on November 13, 2020